Field dossier · from the corpus

CD19

0predicted collisions

Where this field is predicted to collide

No open collisions on this field in the current run.

Most cited work

Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection

20171,847 citationsDOI ↗

Long-term outcomes following CAR T cell therapy: what we know so far

20231,363 citationsDOI ↗

CAR T Cell Therapy for Solid Tumors

2016891 citationsDOI ↗

CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells

2017756 citationsDOI ↗

Signals

4

Papers · in corpus

4.9k

Citations · corpus total

0.0%

Recent share · since 2024

2016–2023

Span · publication years

Who is doing the work

National Cancer InstituteUS2
University of PennsylvaniaUS2
Howard Hughes Medical InstituteUS1
UCSF Helen Diller Family Comprehensive Cancer CenterUS1
Innovative Genomics InstituteUS1
University of California San Francisco Medical CenterUS1
University of California, San FranciscoUS1
Center for Cancer ResearchUS1

Most published researchers

Shaun O’Brien1
Edmund K. Moon1
Steven Μ. Albelda1
Kathryn M. Cappell1
James N. Kochenderfer1
Rachel E. Gate1

Already lives beside

Fields this one already co-publishes with. A predicted collision is a departure from this neighbourhood, not an extension of it.

Antigen4 Cancer research3 T cell3 Cell biology2 Cell therapy2 Immunotherapy2 CRISPR2 Oncology1 Immunology1 B cell1

CD19 · Raz0r Prism